Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
Small, E.J., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B.A., Graff, J.N., Olmos, D., Mainwaring, P.N., Lee, J.Y., Uemura, H., De Porre, P., Smith, A.A., Zhang, K., Lopez-Gitlitz, A., Smith, M.R.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102
Philips, G. K., Halabi, S., Sanford, B. L., Bajorin, D., Small, E. J.
Published in Annals of oncology (01.06.2009)
Published in Annals of oncology (01.06.2009)
Get full text
Journal Article
Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780
SAVARESE, D. M, HALABI, S, HARS, V, AKERLEY, W. L, TAPLIN, M-E, GODLEY, P. A, HUSSAIN, A, SMALL, E. J, VOGELZANG, N. J
Published in Journal of clinical oncology (01.05.2001)
Published in Journal of clinical oncology (01.05.2001)
Get full text
Journal Article
Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial
Ferdinandus, J., Fendler, W.P., Calais, J., Eiber, M., Flavell, R.R., Mishoe, A., Feng, F.Y., Nguyen, H.G., Reiter, R.E., Rettig, M.B., Gartmann, J., Smith, R., Small, E.J., Slavik, R., Carroll, P.R., Herrmann, K., Czernin, J., Hope, T.A.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
7002 ORAL Time to Disease-related Pain After Sipuleucel-T in Asymptomatic Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC): Results From 3 Randomized Phase III Trials
Small, E.J, Higano, C.S, Kantoff, P.W, Whitmore, J.B, Frohlich, M.W, Petrylak, D.R
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Combination External Beam Radiation and Brachytherapy Boost with Androgen Suppression for Treatment of Intermediate-risk Prostate Cancer: Long-term Results of CALGB 99809
Hurwitz, M, Halabi, S, Archer, L, McGinnis, L.S, Kuettel, M.R, DiBiase, S.J, Small, E.J
Published in International journal of radiation oncology, biology, physics (2010)
Published in International journal of radiation oncology, biology, physics (2010)
Get full text
Journal Article
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial
Chi, K.N., Sandhu, S., Smith, M.R., Attard, G., Saad, M., Olmos, D., Castro, E., Roubaud, G., Pereira de Santana Gomes, A.J., Small, E.J., Rathkopf, D.E., Gurney, H., Jung, W., Mason, G.E., Dibaj, S., Wu, D., Diorio, B., Urtishak, K., del Corral, A., Francis, P., Kim, W., Efstathiou, E.
Published in Annals of oncology (01.09.2023)
Published in Annals of oncology (01.09.2023)
Get full text
Journal Article
591P A first-in-human study of FOR46 in men with metastatic castration resistant prostate cancer (mCRPC)
Aggarwal, R.R., Vuky, J., VanderWeele, D., Rettig, M., Heath, E., Nasoff, M., Dorr, A., Liu, B., Small, E.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
2LB Late Breaking A phase II study of abiraterone acetate plus prednisone in patients with castration resistant prostate cancer (CRPC) and no prior therapy with ketoconazole
Ryan, C, Harzstark, A, Fong, L, Lin, A, Kilian, C, Molina, A, Small, E.J
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
1571P COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium
Hong, J., Borno, H.T., Harismendy, O., Yousefi, S., Cinar, P., Rugo, H.S., Kim, M-O., Koshkin, V.S., Bailey, A., McKay, R.R., Small, E.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1751P Impact of squamous histology on clinical outcomes and molecular profiling in metastatic urothelial carcinoma (mUC) patients (pts) treated with newer therapies
Deshmukh, P.S., De Kouchkovsky, I., Zhang, L., Jindal, T., Reyes, K., Hernandez Romero, E., Chan, E., Desai, A., Borno, H.T., Kwon, D., Wong, A., Bose, R., Aggarwal, R., Porten, S., Fong, L., Small, E.J., Chou, J., Friedlander, T., Koshkin, V.S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1404P A phase II study of ZEN-3694 (ZEN), enzalutamide (ENZ), and pembrolizumab (P) in metastatic castration resistant prostate cancer (mCRPC): Interim safety results
Jindal, T., Han, H., Deshmukh, P.S., De Kouchkovsky, I., Kwon, D., Borno, H.T., Koshkin, V.S., Desai, A., Bose, R., Chou, J., Friedlander, T., Small, E.J., Angelidakis, A., Johnson, M.S., Feng, S., Patnaik, A., Fong, L., Alumkal, J., Aggarwal, R.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry
Kwon, D.H., Vashisht, R., Borno, H.T., Aggarwal, R.R., Small, E.J., Butte, A.J., Huang, F.W.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
618P Apalutamide (APA) for advanced prostate cancer in older patients (pts): Combined analysis of TITAN & SPARTAN
Shen, J., Chowdhury, S., Agarwal, N., Karsh, L.I., Oudard, S., Gartrell, B.A., Feyerabend, S., Saad, F., Pieczonka, C.M., Chi, K.N., Brookman-May, S.D., Rooney, B., Bhaumik, A., Londhe, A., McCarthy, S.A., Bevans, K.B., Mundle, S.D., Small, E.J., Smith, M.R., Graff, J.N.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1379P A phase Ib study of a single priming dose of 177Lu-PSMA-617 coupled with pembrolizumab in metastatic castration resistant prostate cancer (mCRPC)
Aggarwal, R., Trihy, L., Hernandez Romero, E., Luch Sam, S., Rastogi, M., De Kouchkovsky, I., Small, E.J., Feng, F., Kwon, D., Friedlander, T., Borno, H.T., Bose, R., Chou, J., Koshkin, V.S., Desai, A., Feng, S., Angelidakis, A., Johnson, M.S., Fong, L., Hope, T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
221P Patient-reported sexual and urinary function in nonmetastatic castration-resistant prostate cancer (nmCRPC) when treated with apalutamide (APA) vs placebo (PBO) and ongoing androgen deprivation therapy (ADT) in SPARTAN
Uemura, H., Lee, J.Y., Oudard, S., Hadaschik, B.A., Saad, F., Cella, D., Basch, E., Graff, J.N., Dibaj, S., Li, S., Brookman-May, S.D., De Porre, P., Bevans, K., Trudeau, J., Smith, M.R., Small, E.J.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
632P Health-related quality of life (HRQoL) at final analysis of the SPARTAN study of apalutamide (APA) vs placebo (PBO) in patients (pts) with non-metastatic castration-resistant prostate cancer (nmCRPC) receiving androgen deprivation therapy (ADT)
Oudard, S., Hadaschik, B.A., Saad, F., Cella, D., Basch, E., Mainwaring, P.N., Graff, J.N., Dibaj, S., Li, S., Brookman-May, S.D., De Porre, P., Trudeau, J.J., Small, E.J., Smith, M.R.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer††Presented in part at the 2019 GU ASCO and ASCO Annual Meeting (Halabi S, Dutta S, Chi KN, et al. PSA decline and objective response rates in White (W), Black (B), and Asian men with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2019;37(suppl; abstr 5021). https://doi.org/10.1200/JCO.2019.37.15_suppl.5021.)
Halabi, S., Dutta, S., Tangen, C.M., Rosenthal, M., Petrylak, D.P., Thompson, I.M., Chi, K.N., De Bono, J.S., Araujo, J.C., Logothetis, C., Eisenberger, M.A., Quinn, D.I., Fizazi, K., Morris, M.J., Higano, C.S., Tannock, I.F., Small, E.J., Kelly, W.K.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
Apalutamide (APA) and overall survival (OS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Updated results from the phase III SPARTAN study
Smith, M.R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B.A., Graff, J.N., Olmos, D., Mainwaring, P.N., Lee, J.Y., Uemura, H., De Porre, P., Smith, A., Zhang, K., Lopez-Gitlitz, A., Small, E.J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article